Wordt geladen...
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
PURPOSE: High-dose-rate brachytherapy (HDR-BT) delivered in a single fraction as monotherapy is a potential treatment modality for low- and intermediate-risk prostate cancer (LIR-PC); however, outcome data with this technique remain limited. Here we describe our institutional HDR monotherapy experie...
Bewaard in:
| Gepubliceerd in: | J Contemp Brachytherapy |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Termedia Publishing House
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854868/ https://ncbi.nlm.nih.gov/pubmed/31749847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2019.89367 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|